Figure 1
Figure 1. Disposition of trial participants. Dose of imatinib received, duration of treatment with imatinib, and reason for discontinuation of imatinib are shown.

Disposition of trial participants. Dose of imatinib received, duration of treatment with imatinib, and reason for discontinuation of imatinib are shown.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal